http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26307739

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 506
issn 0277-1691
issueIdentifier 6
pageRange 497-506
publicationName International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
startingPage 497
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4a79863896a5d8c9677f07bd150ee8b6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b4f051e2291e02d68079648597635435
bibliographicCitation Bakkar RM, Xie S, Urbauer DL, Djordjevic B, Vu K, Broaddus RR. Intact PTEN Expression by Immunohistochemistry is Associated With Decreased Survival in Advanced Stage Ovarian/Primary Peritoneal High-grade Serous Carcinoma. International Journal of Gynecological Pathology. 2015 Nov;34(6):497–506. doi: 10.1097/pgp.0000000000000205.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc31dc7513cfd7c7903e36cb3cc9974b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caa09923424b4629415f96989b0d7ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9daa074148d247fcaf2372a5e8c52075
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd96f2740dc5c0db2a7ba4404dce3282
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca81bbbee2ec2e4ac04cdaa5fbff1428
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a561e232014ee45a9c01cc06e45cc7de
date 201511
identifier https://doi.org/10.1097/pgp.0000000000000205
https://pubmed.ncbi.nlm.nih.gov/26166715
isPartOf https://portal.issn.org/resource/ISSN/0277-1691
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4296
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Intact PTEN Expression by Immunohistochemistry is Associated With Decreased Survival in Advanced Stage Ovarian/Primary Peritoneal High-grade Serous Carcinoma
discusses http://id.nlm.nih.gov/mesh/M0479128
http://id.nlm.nih.gov/mesh/M0282104
http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014408Q000032
http://id.nlm.nih.gov/mesh/D010534Q000473
http://id.nlm.nih.gov/mesh/D051059Q000096
http://id.nlm.nih.gov/mesh/D010051Q000473
http://id.nlm.nih.gov/mesh/D018284Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D020133
http://id.nlm.nih.gov/mesh/D010051Q000401
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D010534Q000401
http://id.nlm.nih.gov/mesh/D060787
http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D018284Q000401
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9950
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7816
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50557
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5728

Total number of triples: 57.